| Income Statement |
| Total Revenue | 34.03M |
|
| Revenues (USD) | 34.03M |
| Cost of Revenue | 24.75M |
| Gross Profit | 9.28M |
| Operating Expenses | 13.58M |
| Research and Development Expense | 4.10M |
| Selling, General and Administrative Expense | 9.48M |
| Operating Income | -4.30M |
| Net Income | -5.07M |
| Net Income Common Stock | -5.07M |
| Net Income Common Stock (USD) | -5.07M |
| Consolidated Income | -3.15M |
| Net Income to Non-Controlling Interests | 1.92M |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -5.07M |
| Earning Before Interest & Taxes (USD) | -5.07M |
| Weighted Average Shares | 143.47M |
| Weighted Average Shares Diluted | 143.47M |
| Balance Sheet |
| Cash and Equivalents | 74.52M |
| Cash and Equivalents (USD) | 74.52M |
| Trade and Non-Trade Receivables | 40.65M |
| Current Assets | 131.58M |
| Property, Plant & Equipment Net | 17.54M |
| Total Assets | 149.18M |
| Debt Current | 1.18M |
| Total Debt | 6.38M |
| Current Liabilities | 18.35M |
| Debt Non-Current | 5.20M |
| Total Liabilities | 23.55M |
| Accumulated Retained Earnings (Deficit) | -226.56M |
| Accumulated Other Comprehensive Income | 23.00K |
| Shareholders Equity | 125.64M |
| Shareholders Equity (USD) | 125.64M |
| Assets Non-Current | 17.60M |
| Total Debt (USD) | 6.38M |
| Deferred Revenue | 413.00K |
| Inventory | 11.51M |
| Liabilities Non-Current | 5.20M |
| Trade and Non-Trade Payables | 9.76M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.06M |
| Net Cash Flow from Financing | 16.82M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 12.15M |
| Capital Expenditure | -1.82M |
| Issuance (Purchase) of Equity Shares | 16.82M |
| Net Cash Flow from Investing | -1.82M |
| Net Cash Flow from Operations | -2.85M |
| Effect of Exchange Rate Changes on Cash | 13.00K |
| Share Based Compensation | 2.54M |